Authors: Melanie Walker, Emma M Federico, Douglas B Kell, Christopher Dupont, Amy Proal, Etheresia Pretorius
Published: 2023-06-15
DOI: 10.1161/circ.146.suppl_1.15637
Source: Full article
LongCovid or Post-Acute Sequelae of COVID-19 (PASC) is a diagnosis given to patients who experience a wide range of debilitating chronic symptoms after infection with SARS-CoV-2. The majority of individuals are PCR negative, indicating microbiological recovery. There are currently few LongCovid/PASC blood-based biomarkers. We used fluorescence microcopy to identify unique fibrin/amyloid micro-thrombosis and hyperactivated platelets in individuals with PASC. These fibrin/amyloid microclots may impede blood flow to tissue.